Literature DB >> 11018310

Cardiovascular risk factors and Alzheimer's disease: a genetic association study in a population aged 85 or over.

L Myllykangas1, T Polvikoski, R Sulkava, A Verkkoniemi, P Tienari, L Niinistö, K Kontula, J Hardy, M Haltia, J Pérez-Tur.   

Abstract

Increasing evidence suggests a relation between vascular disorders and late-onset Alzheimer's disease (AD). We performed an association analysis of low-density lipoprotein receptor-related protein (LRP), lipoprotein lipase (LPL), and angiotensin converting enzyme (ACE) genes, known to be involved in vascular disorders, and AD. Genotyping was carried out in 113 patients with clinically defined Alzheimer's disease (NINCDS-ADRDA criteria) and 203 non-demented controls in a prospective, population-based study of people aged 85 years or over (Vantaa 85+ Study). Corresponding analysis was performed on 121 neuropathologically verified AD patients (CERAD criteria) and 75 controls derived from the same study population. We did not find significant associations between the polymorphisms studied and AD. However, analysis of the LPL polymorphism showed a weak trend (uncorrected P-value 0.095) towards protection against neuropathologically defined AD. Our study is based on very elderly Finns. Therefore, further studies are warranted in other populations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018310     DOI: 10.1016/s0304-3940(00)01467-1

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Angiotensin-converting enzyme deletion allele is beneficial for the longevity of Europeans.

Authors:  Matea Zajc Petranović; Tatjana Skarić-Jurić; Nina Smolej Narančić; Zeljka Tomas; Petra Krajačić; Jasna Miličić; Maja Barbalić; Spomenka Tomek-Roksandić
Journal:  Age (Dordr)       Date:  2011-05-26

2.  C677T methylentetrahydrofulate reductase and angiotensin converting enzyme gene polymorphisms in patients with Alzheimer's disease in Iranian population.

Authors:  Mohammad Reza Keikhaee; Susan Bany Hashemi; Hossein Najmabadi; Maryam Noroozian
Journal:  Neurochem Res       Date:  2006-08-12       Impact factor: 3.996

Review 3.  Lipoprotein lipase in the brain and nervous system.

Authors:  Hong Wang; Robert H Eckel
Journal:  Annu Rev Nutr       Date:  2012-04-23       Impact factor: 11.848

4.  Lipoprotein Lipase HindIII Intronic Polymorphism in a Subset of Iranian Patients with Late-Onset Alzheimer's Disease.

Authors:  Azadeh Sayad; Mehrdad Noruzinia; Mahdi Zamani; Mohammad Hossein Harirchian; Anoshirvan Kazemnejad
Journal:  Cell J       Date:  2012-06-13       Impact factor: 2.479

Review 5.  Population-based neuropathological studies of dementia: design, methods and areas of investigation--a systematic review.

Authors:  Julia Zaccai; Paul Ince; Carol Brayne
Journal:  BMC Neurol       Date:  2006-01-09       Impact factor: 2.474

6.  Angiotensin-converting enzyme insertion/deletion polymorphism is not a major determining factor in the development of sporadic Alzheimer disease: evidence from an updated meta-analysis.

Authors:  Xue-bin Wang; Ning-hua Cui; Jie Yang; Xue-ping Qiu; Jia-jia Gao; Na Yang; Fang Zheng
Journal:  PLoS One       Date:  2014-10-31       Impact factor: 3.240

7.  Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study.

Authors:  Nienke Legdeur; Maryam Badissi; Stephen F Carter; Sophie de Crom; Aleid van de Kreeke; Ralph Vreeswijk; Marijke C Trappenburg; Mardien L Oudega; Huiberdina L Koek; Jos P van Campen; Carolina J P W Keijsers; Chinenye Amadi; Rainer Hinz; Mark F Gordon; Gerald Novak; Jana Podhorna; Erik Serné; Frank Verbraak; Maqsood Yaqub; Arjan Hillebrand; Alessandra Griffa; Neil Pendleton; Sophia E Kramer; Charlotte E Teunissen; Adriaan Lammertsma; Frederik Barkhof; Bart N M van Berckel; Philip Scheltens; Majon Muller; Andrea B Maier; Karl Herholz; Pieter Jelle Visser
Journal:  BMC Geriatr       Date:  2018-11-26       Impact factor: 3.921

8.  Angiotensin-converting enzyme polymorphisms AND Alzheimer's disease susceptibility: An updated meta-analysis.

Authors:  Xiao-Yu Xin; Ze-Hua Lai; Kai-Qi Ding; Li-Li Zeng; Jian-Fang Ma
Journal:  PLoS One       Date:  2021-11-24       Impact factor: 3.240

9.  APOE and ACE polymorphisms and dementia risk in the older population over prolonged follow-up: 10 years of incidence in the MRC CFA Study.

Authors:  H A D Keage; F E Matthews; A Yip; L Gao; C McCracken; I G McKeith; D C Rubinsztein; C Brayne
Journal:  Age Ageing       Date:  2009-11-24       Impact factor: 10.668

10.  Lack of association between angiotensin-converting enzyme and dementia of the Alzheimer's type in an elderly Arab population in Wadi Ara, Israel.

Authors:  Abdalla Bowirrat; Jing Cui; Kristin Waraska; Robert P Friedland; Marlene Oscar-Berman; Lindsay A Farrer; Amos Korczyn; Clinton T Baldwin
Journal:  Neuropsychiatr Dis Treat       Date:  2005-03       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.